Why A Biotech M&A Wave May Hit This Winter

Biotech stocks have slumped from their August highs. But experts say renewed M&A, likely coming, could catalyze them. The post Why A Biotech M&A Wave May Hit This Winter appeared first on Investor's Business Daily.